Evidence map›Paper›PMID 30092697›Full record

ReviewUpsala journal of medical sciences2019

The Swedish Heart Failure Registry: a living, ongoing quality assurance and research in heart failure.

Gianluigi Savarese, Peter Vasko, Åsa Jonsson, Magnus Edner, Ulf Dahlström, Lars H Lund

Registry-linked trialAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Upsala journal of medical sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04829591 (The Jordanian Heart Failure Registry), which is not on this map. Cited by 68 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04829591 completednot on this mapstarted 2021, after this paper: background citation

The Jordanian Heart Failure Registry (JoHFR)

TypeobservationalSponsorJordan Cardio Vascular Research GroupRan2021 to 2023Enrolled2,219ConditionsHeart Failure, Chronic Heart Failure, Acute Heart FailureArmsobservational
3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Observational
  12. Observational
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Observational
  20. Associations between cardiac resynchronization therapy and clinical outcomes according to the atrial fibrillation status in patients with heart failure with reduced ejection fraction.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Observational

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gianluigi Savaresea Cardiology Unit, Department of Medicine , Karolinska Institutet , Stockholm , Sweden.
Peter Vaskob Department of Medicine , Växjö Hospital , Växjö , Sweden.
Åsa Jonssonc Department of Medicine , Ryhov County Hospital , Jönköping , Sweden.
Magnus Ednera Cardiology Unit, Department of Medicine , Karolinska Institutet , Stockholm , Sweden.
Ulf Dahlströmd Department of Cardiology and Department of Medical and Health Sciences , Linköping University , Linköping , Sweden.
Lars H Lunda Cardiology Unit, Department of Medicine , Karolinska Institutet , Stockholm , Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart failure (HF) represents a global pandemic. Although in HF with reduced ejection fraction (HFrEF) randomized controlled trials have provided effective treatments, prognosis still remains poor, with signals of undertreatment. HF with mid-range EF (HFmrEF) has no evidence-based therapy, and its characterization is ongoing. Trials in HF with preserved EF (HFpEF) have failed to provide any effective treatment, but there are several concerns about their design. Thus, current challenges in the HF field are: 1) optimizing the use of existing treatments in HFrEF; 2) developing and proving efficacy of new treatments, and of new use of existing treatments in HFpEF and HFmrEF. Here we describe how registry-based research can improve knowledge addressing the unmet needs in HF, and in particular we focus on the contribution of the Swedish Heart Failure Registry to this field.

Indexed as

RegistriesCardiologyClinical Trials as TopicEvidence-Based MedicineHeart FailureHospitalizationHumansOutcome Assessment, Health CarePandemicsPrognosisProspective StudiesQuality of Health CareRandomized Controlled Trials as TopicResearch DesignRisk FactorsSwedenHeart failureregistryRiksSviktSwedeHF

Identifiers

PMID30092697
PMCPMC6450584

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.